Griseofulvin: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) Blanked the page |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Griseofulvin}} | |||
{{CMG}}; {{AE}} {{AZ}} | |||
==Overview== | |||
==Category== | |||
'''GRIFULVIN V<sup>®</sup>''' | |||
==US Brand Names== | |||
==FDA Package Insert== | |||
'''| [[Griseofulvin description|Description]]''' | |||
'''| [[Griseofulvin clinical pharmacology|Clinical Pharmacology]]''' | |||
'''| [[Griseofulvin microbiology|Microbiology]]''' | |||
'''| [[Griseofulvin indications and usage|Indications and Usage]]''' | |||
'''| [[Griseofulvin contraindications|Contraindications]]''' | |||
'''| [[Griseofulvin warnings and precautions|Warnings and Precautions]]''' | |||
'''| [[Griseofulvin adverse reactions|Adverse Reactions]]''' | |||
'''| [[Griseofulvin drug interactions|Drug Interactions]]''' | |||
'''| [[Griseofulvin overdosage|Overdosage]]''' | |||
'''| [[Griseofulvin clinical studies|Clinical Studies]]''' | |||
'''| [[Griseofulvin dosage and administration|Dosage and Administration]]''' | |||
'''| [[Griseofulvin how supplied|How Supplied]]''' | |||
'''| [[Griseofulvin labels and packages|Labels and Packages]]''' | |||
==Mechanism of Action== | |||
==References== | |||
{{Reflist|2}} | |||
[[Category:Antibiotics]] | |||
[[Category:Wikinfect]] | |||
Revision as of 01:11, 5 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Overview
Category
GRIFULVIN V®
US Brand Names
FDA Package Insert
| Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages